Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Nabil F. Saba, Scott A Kono, Jennifer Robin Mendel, Selwyn J Hurwitz, Taofeek Kunle Owonikoko, Colleen Margaret Lewis, Donald Harvey, Jaqueline Willemann Rogerio, Zhengjia Chen, Trad Wadsworth, Mark El-Deiry, Amy Y. Chen, Kristin Higgins, Suresh S Ramalingam, Jonathan Jay Beitler, Dong M Shin, Fadlo Raja Khuri
Institutions: Emory University, Winship Cancer Institute, Kaiser Permanente
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2597562879